China Everbright Limited (Everbright, stock code: 165.HK) was established in Hong Kong in 1997 with over 20 years’ experience in PE investments and asset management. It is China’s leading cross-border investment and asset management company, backed by its parent company China Everbright Group. Through the private equity funds, venture capital funds, industry funds, mezzanine funds, fund of funds, fixed income and equity funds it manages, Everbright cultivates a number of high-growth-potential enterprises together with its investors. While closely following the development requirements of Chinese companies, it also introduces the best overseas technologies into the Chinese market, providing multifaceted services to Chinese and overseas clients.

Moreover, via its principal investment, Everbright is cultivating CALC, the largest independent aircraft leasing operator in China; incubating CEL Terminus, a unicorn enterprise specialising in AI and Internet of Things; and also integrating high-end elderly care platforms in China to build a proprietary and quality senior care brand.

As of 31 December 2018, Everbright managed 62 funds and a total AUM of HK$143.5 billion. Through both proprietary funds and the funds it manages, Everbright has invested in companies both in China and globally, including China UMS, Goldwind, CECEP Wind-power Corporation, HC SemiTek, BGI, Betta Pharmaceuticals Co. Ltd., Amcare, LifeTech Scientific Corporation, Focus Media, iQiYi, SenseTime, NIO, Tirana International Airport, Boreal, Burke Porter Group, Wish, Xjet and Satixfy, etc. It has invested in a total of over 300 companies, covering fields including real estate, aircraft leasing, medical & healthcare, elderly care, new energy, infrastructure, high-level manufacturing, advanced technology and cultural consumption. Of these, more than 150 companies have been listed in China or overseas, or were listed but have since withdrawn due to mergers and acquisitions.

Newplan

Lifetech Scientific Co, Ltd

NetEase Cloud Music

Ambrx

iSoftStone

Amcare Women's and Children's Hospital

China Everbright Limited

China Everbright Limited, through its subsidiaries, engages in the investment activities and provision of financial services in Hong Kong and Mainland China. The company invests in unlisted equity securities or equity derivatives, as well as in the areas of new economy, artificial intelligence and advanced manufacturing, new energy, medical care and senior healthcare, overseas acquisition and infrastructure, real estate, aircraft industry chain, mezzanine fund, and others. It also focuses on investing in aircraft leasing, artificial intelligence of things, and elderly care industry platforms; and investing in equity, debts, structured products, and other products. In addition, the company provides a range of financial services, including asset management, investment management, and investment advisory services related to absolute return funds, bond funds, and equity funds, as well as offers management, treasury management, money lending, fund management, property and project investment, venture capital, leasing, and consultancy services. The company was founded in 1997 and is headquartered in Hong Kong, Hong Kong. China Everbright Limited is a subsidiary of Honorich Holdings Limited.

0165

COM:EVERBRIGHT

China Everbright Limited

Last Close

5.26

21/11 08:08

Market Cap

6.72B

Beta: -

Volume Today

1.36M

Avg: -

Filings Not Available